Receptor-targeted recombinant adenovirus conglomerates: A novel molecular conjugate vector with improved expression characteristics

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8563-8571

  Schwarzenberger, Paul ^a,c   Hunt, Jay D ^a   Robert, Everett ^a   Theodossiou, Chris ^a   Kolls, Jay K ^a,b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Maxillofacial Prosthetics Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIGAND; LUCIFERASE; POLYLYSINE; STREPTAVIDIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONJUGATE; DNA INTEGRATION; ENDOSOME; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC ANALYSIS; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS GENE; VIRUS RECOMBINANT;

EID: 0030816491     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8563-8571.1997     Document Type: Article

References (41)

1. Arcasoy, S. M., J. D. Latoche, M. Gondor, B. R. Pitt, and J. M. Pilewski. 1997. Polycations increase ihe efficiency of adenovirus-medialed gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4:32-38.
2. Cassel, A., M. Cottler-Fox, S. Doren, and C. E. Dunbar. 1993. Retroviral-mediated gene transfer into CD34 enriched human peripheral blood stem cells. Exp. Hematol. 21:585-591.
3. Chen, L., M. Pulsipher, D. Chen, C. Sieff, A. Elias, H. A. Fine, and D. W. Kufe. 1996. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J. Clin. Invest. 98:2539-2548.
4. Chiou, H. C., M. V. Tangco, S. M. Levine, D. Robertson, K. Kormis, C. H. Wu, and G. Y. Wu. 1994. Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. Nucleic Acids Res. 22:5439-5446.
5. Cotton, M., E. Wagner, E. Zatloukal, S. Phillips, D. T. Curiel, and M. Birnstiel. 1992. High efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA 89:6094-6098.
6. Dai, Y., E. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
7. Fasbender, A., J. Zabner, M. Chillon, T. O. Moninger, A. P. Puga, B. L. Davidson, and M. J. Welsh. 1997. Complexes of adenovirus with polycationic polymers and ctionic lipids increase the efficiency of gene transfer in vitro and in vivo. J. Biol. Chem. 272:6479-6489.
8. Ferkol, T., J. C. Perales, E. Eckman, C. Kaetzel, R. Hanson, and P. B. Davis. 1995. Gene transfer into the epithelium of animals by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. 95:493-502.
9. Fisher, K. J., and J. M. Wilson. 1994. Biochemical and functional analysis of an adenovirus based ligand complex for gene transfer. Biochem. J. 299:49-58.
10. Friedmann, T. 1994. Gene therapy for neurological disorders. Trends Genet. 10:210-214.
11. Gahlmann, R., and W. Doerfler. 1983. Integration of viral DNA into the genome of the adenovirus type 2 hamster cell line HE5 without loss or alteration of cellular nucleotides. Nucleic Acids Res. 11:7347-7359.
12. Graham, F. L., and L. Prevec. 1991. Gene transfer and expression protocols: manipulation of adenovirus vectors, p. 109-128. In E. J. Murray (ed.). Methods in molecular biology. Humana Press Inc., Clifton, N.J.
13. Hiroshi, N., C. H. Wu, and G. Y. Wu. 1991. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. J. Biol. Chem. 266:14143-14146.
14. Kay, M. A., and S. L. C. Woo. 1994. Gene therapy for metabolic disorders. Trends Genet. 10:253-257.
15. Knowles, M. R., K. W. Hohneker, Z. Zhou, J. C. Olsen, T. L. Noah, P. Hu, M. W. Leigh, J. F. Engelhardt, L. J. Edwards, K. R. Jones, M. Grossman, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1995. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 133:823-831.
16. Kolls, J., K. Peppel, M. Silvia, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene-transfer. Proc. Natl. Acad. Sci. USA 91:215-219.
17. Konan, V., A. Sahota, F. L. Graham, and M. W. Taylor. 1991. Transduction of the CHO aprt gene into mouse L cells using an adeno-5/APRT recombinant virus. Somatic Cell Mol. Genet. 17:359-368.
18. Kozarsky, K. F., D. R. McKinley, L. L. Austin, S. E. Raper, L. D. Stratford-Perricaudet, and J. M. Wilson. 1994. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269:13695-13702.
19. Manthorpe, M., F. Cornefert-Jensen, J. Hartikka, J. Felgner, and V. Dwarki. 1993. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4:419-431.
20. Michael, S. I, C. H. Huang, M. U. Romer, E. Wagner, P. C. Hu, and D. T. Curiel. 1993. Binding-incompetent adenovirus faciltates molecular conjugate-mediate gene transfer by the receptor-mediated endocytosis pathway. J. Biol. Chem. 268:6866-6869.
21. Miller, N., and R. Vile. 1995. Targeted vectors for gene therapy. FASEB J. 9:190-199.
22. Mitani, K., F. L. Graham, and T. C. Caskey. 1994. Transduction of human bone marrow by adenoviral vector. Hum. Gene Ther. 5:941-948.
23. Mitani, K., F. L. Graham, C. T. Caskey, and S. Kochanek. 1995. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA 92:3854-3858.
24. Rich, D. P., L. A. Couture, L. M. Cardoza, V. M. Guggio, M. J. Welsh, A. E. Smith, and R. J. Gregory. 1993. Development and analysis of recombinant adenovirus for gene therapy of cystic fibrosis. Hum. Gene Ther. 4:461-476.
25. Roux, P., P. Jeanteur, and M. Piechaczyk. 1989. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility. Proc. Natl. Acad. Sci. USA 86:9079-9083.
26. Schwarzenberger, P., S. E. Spence, J. M. Gooya, D. M. Michiel, F. W. Ruscetti, and J. R. Keller. 1996. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87:472-478.
27. Seth, P., D. Fitzgerald, H. Ginsberg, M. Willingham, and I. Pastan. 1984. Evidence that the penton base of adenovirus is involved in potentiation of toxicity of pseudomonas exotoxin conjugated to epidermal growth factor. Mol. Cell. Biol. 4:1528-1533.
28. Severne, Y., S. Wieland, W. Schaffner, and S. Rusconi. 1988. Metal binding finger structures in the glucocorticoid receptor defined by site directed mutagenesis. EMBO J. 7:2503-2508.
29. Shun, I., M. Brown, J. S. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
30. Skutelsky, E., and D. Danon. 1976. Redistribution of surface anionic sites on the luminalfront of blood vessel endothelium after interaction with polycationic ligand. J. Cell Biol. 71:232-241.
31. Vieweg, J., and E. Gilboa. 1995. Considerations for the use of cytokine secreting tumor cell preparations for cancer treatment. Cancer Invest. 13: 193-201.
32. Wagner, E. (Vienna, Austria). Personal communication.
33. Wagner, E., K. Zatloukal, M. Cotton, and M. Birnstiel. 1992. Coupling of adenovirus to transferrinpolysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89:6099-6103.
34. Wattel, E., M. Vanrumbeke, M. A. Abina, N. Cambier, C. Preudhomme, H. Haddada, and P. Fenaux. 1996. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia 10:171-174.
35. Wickham, T. J., P. W. Roelvink, D. E. Brough, and I. Kovesdi. 1996. Adenovirus targeted to heparin-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1570-1573.
36. Wu, G. Y., and C. H. Wu. 1988. Receptor mediated gene delivery and expression in vivo. J. Biol. Chem. 263:14621-14626.
37. Wu, G. Y., and C. H. Wu. 1986. Receptor mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262:4429-4432.
38. Yang, Y., F. Nunes, K. Berencsi, E. Furth, E. Goenczoel, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1 deleted adenovirus for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
39. Yang, Y., F. A. Nunes, E. Goencoel, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.
40. Zatloukal, K., W. Schmidt, M. Cotten, E. Wagner, G. Stingl, and M. L. Birnstiel. 1993. Somatic gene therapy for cancer: the utility of transferrinfection in generating 'tumor vaccines.' Gene 135:199-207.
41. Zenke, M., P. Steinlein, E. Wagner, and M. Birnstiel. 1990. Receptor mediated endocytosis of transferrinpolycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc. Natl. Acad. Sci. USA 87: 3655-3659.